UCB - PE Price to Earnings


UCB reported 29.7 in PE Price to Earnings for its fiscal semester ending in December of 2025.





Pe Change Date
Alcon AG 42.44 6.03 Jun/2026
Almirall 79.43 0.3 Dec/2025
Amarin 91.05 88.3 Jun/2023
argenx SE 33.43 2.1 Sep/2026
AstraZeneca 24.63 0.71 Sep/2026
Bayer 4.14 0.74 Jun/2026
Genmab 16.04 1.05 Jun/2026
GlaxoSmithKline 9.72 0.9 Sep/2026
GRIFOLS 14.71 3.73 Jun/2026
Hikma Pharmaceutical 10.43 3.72 Dec/2025
Lakefront Biotherapeutics 2.68 0.14 Jun/2026
Lonza 34.34 2.58 Dec/2025
Merck 17.21 4.47 Jun/2026
Novartis 19.17 3.24 Sep/2026
Orion 17.23 1.3 Jun/2026
Recordati 22.75 5.09 Jun/2026
Roche Holding 16.48 0.39 Jun/2026
Sanofi 22.34 3.38 Sep/2026
UCB 29.7 5.52 Dec/2025
Unibail Rodamco 10.36 0.43 Dec/2025